Dr Matthew Jenner

Consultant Haematologist


Specialises in

My main clinical interests are the diagnosis and management of haematological malignancies utilising chemotherapy, novel agents and high dose chemotherapy and stem cell transplantation.

Treatment information

Some of the principal treatments carried out by Dr Matthew Jenner at Spire include:


Get in touch


Marketing Information

Spire would like to provide you with marketing information about products and services offered by Spire and by selected third-party partners. If you do not consent for us to process your personal data for marketing activities, we will still be able to contact you about your enquiry.

We may contact you by email, SMS or phone about your enquiry. If we try to contact you by phone (mobile and/or landline) and you are not available, we may leave you a voicemail message. We may also use your details to contact you about patient surveys we use for improving our service or monitoring outcomes, which are not a form of marketing.

Additional information

Clinical interests


Qualification and professional memberships

Professional memberships

Member of NICE myeloma clinical guidelines group. Guidelines currently under development.

Member of NCRI haematological oncology myeloma clinical trials subgroup.

Research and publications

Dr Jenner has conducted clinical research into the optimal treatment strategies for myeloma and in to the prognostic significance of cytogenetic abnormalities in myeloma. He has also participated in the development of BCSH and NICE myeloma guidelines.


Co-authored 2013 update to British Committee of Standards in Haematology guidelines for the diagnosis and management of multiple myeloma.

Contact information

Private secretary Sharon Ward
Private secretary telephone 023 8076 4390
Private secretary fax 023 8076 4358
Private secretary email sharon.ward@spirehealthcare.com